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Anti-recombinant human basic fibroblast growth factor (rbFGF) antibodies effaeiently i hibited the basal proliferation 
of bovine pulmonary artery endothelial (BAE) cells. The cell-free extract o  BAE cells stimulated the proliferation of 
bovine capillary endothelial cells and this activity was completely abolished by the antibodies. Furthermore, on hepa in 
HPLC the activity was eluted at exactly the same retention time as that for authentic pituitary bFGF. These observations 
directly indicate that the BAE cells produce bFGF that stimulates their own basal growth by binding to specific receptors 
expressed on the cell surface. 
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1. INTRODUCTION 
bFGF is a potent mitogen of vascular and 
capillary endothelial cells [1-3] and has been 
demonstrated to induce angiogenesis [2,4,5]. 
Vascular and capillary endothelial cells produce 
bFGF [6,7] and specific receptors are expressed on 
the cell surface [8-11]. These observations suggest 
that bFGF might be an autocrine growth factor of 
endothelial cells. However, there is no direct and 
clear evidence to support this hypothesis. It re- 
mains unsolved whether bFGF produced by the en- 
dothelial cells exerts its mitogenic effect via 
receptors expressed on the cell surface. To assess 
this possibility, we have studied the effect of anti- 
rbFGF antibodies on the growth of BAE cells and 
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have found that the antibodies efficiently inhibit 
the growth of the cells. To the best of our 
knowledge, this is the first report directly revealing 
that the bFGF-dependent  autocrine growth 
mechanism participates in the growth of vascular 
endothelial cells. 
2. MATERIALS  AND METHODS 
2.1. Materials 
Homogeneous bovine pituitary bFGF was obtained as 
described previously [12]. Bovine brain acidic FGF was pur- 
chased from R & D Systems (USA) and rabbit normal IgG from 
Miles Laboratories (USA). Tissue culture multiwell plates 
(2 cmE/well) were obtained from Flow Laboratories. 
2.2. Cell culture 
BAE cells were purchased from American Type Culture Col- 
lection (CCL-207). They were cultured in Dulbecco's modified 
Eagle's medium supplemented with 10070 heat-inactivated fetal 
calf serum (MA Bioproducts, MD, USA), 20 units/ml penicillin 
G, and 100/zg/ml streptomycin. The cells were used between 
passage numbers 17 and 21. BCE cells were kindly provided by 
Dr J. Folkman and Ms C. Butterfield, Harvard Medical School. 
The cells were cultured in the same medium supplemented with 
rbFGF (2 ng/ml) in a gelatin-coated plastic flask under an at- 
mosphere of 10070 CO2. The cells were used between passage 
numbers 9 and ll. 
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2.3. Preparation of  cell-free extract 
Confluent BAE cells (CCL-207, 3 x 107 cells/750 cm 2) were 
detached using a cell scraper (C.A. Greiner und S6hne, FRG) 
and were washed twice with phosphate buffered saline (PBS). 
The washed cells were suspended in 0.6 ml PBS and were lysed 
by sonication (25 s at 0°C). The cell lysate was centrifuged at 
12000 rpm in a microfuge for 5 min at 0°C to obtain 0.7 ml of 
cleared cell-frec extract. It was stored in aliquots at - 20°C un- 
til used. 
2.4. Fractionation of  cell-free extract 
The cell-free xtract (0.5 ml) was filtered with a 0.45/~m filter 
and applied to a heparin affinity HPLC column equilibrated at
room temperature with 20 mM sodium phosphate buffer (pH 
7.4) containing 0.4 M NaCI. The proteins were eluted with an 
NaCI gradient (0.4 M-I.7 M) at a flow rate of 1 ml/min. Frac- 
tions (1 ml) were collected and the mitogenic activity for BCE 
cells was measured. 
2.5. PreParation of  rbFGF and anti-rbFGF antibodies 
Recombinant human bFGF was expressed in E. coli and 
purified to homogeneity as described [13] with a slight 
modification. Briefly, E. coli cells were disrupted by BEAD- 
BEATER (Biospec Products, USA), and the xtract was applied 
to a CM-Toyopearl (Tosoh, Tokyo, Japan) column equilibrated 
with 50 mM sodium phosphate buffer (pH 6.0). Proteins were 
eluted with 50 mM sodium phosphate buffer (pH 6.0) contain- 
ing 1 M NaC1. The active fractions were pooled and applied to 
a heparin affinity HPLC column (Shodex AF pack, Showa- 
denko, Japan) and proteins were eluted with an NaCI gradient. 
The peak eluate consisted of highly purified rbFGF which gave 
a single band on SDS-polyacrylamide gelelectrophoresis (SDS- 
PAGE) (fig.2, lane 3). 
Rabbits were immunized twice at an interval of two weeks by 
multisite intradermal injections of 300/~g each of rbFGF 
emulsified with complete Freund's adjuvant. A week later, the 
rabbits were boosted with an intravenous injection of 300/zg 
rbFGF dissolved in saline. The titer of the antiserum after the 
booster injection was over 1 x 106 as determined in an ELISA. 
Whole IgG fractions were obtained from the antiserum by pro- 
tein A-Sepharose affinity chromatography [14] and used 
throughout this work. 
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Fig.1. Effect of anti-bFGF antibodies on the proliferation of 
BAE cells. BAE (CCL-207) cells were plated at a density of 1 × 
104 cells per well (2 cm 2) and cultured in the presence (+) or 
absence ( - )  of rbFGF (10 ng/ml). Anti-rbFGF antibodies 
(solid bars) or control IgG (open bars) were added at the 
beginning of culture. Dotted bars epresent the growth for BAE 
cells in the absence of antibodies. After 3 days, the cells were 
trypsinized and counted in duplicate with a Coulter particle 
counter. 
2.6. Immunoblot analysis 
SDS-PAGE was performed as described [15] and im- 
munoblotting was carried out essentially as described previously 
[16]. The nitrocellulose paper was incubated with anti-rbFGF 
antibodies and the antigen-antibody complex was visualized by 
successive incubation with peroxidase-conjugated anti-rabbit 
lgG mouse IgG (BioRad, CA, USA), 4-chloro-l-naphthol and 
H202. 
3. RESULTS 
Fig. 1 shows that  the growth  o f  BAE (CCL-207)  
cells was s t imu la ted  by exogenous  rbFGF.  The 
cells were able to grow in the absence  o f  exogenous  
rbFGF a l though the growth  rate was somewhat  
smal ler .  To  examine  the par t i c ipat ion  o f  bFGF in
Fig.2. Immunoblot analysis with anti-rbFGF antibodies. 
Molecular mass markers (lane 1), purified rbFGF (lane 3, 2/~g; 
lane 5, 0.2 ~g) and whole E. coil proteins (lanes 2 and 4, 50 ~g) 
were subjected to SDS-PAGE. Lanes: 1-3, stained with 
Coomassie brilliant blue R-250; 4-5, the proteins were 
transferred tonitrocellulose paper and visualized using the anti- 
rbFGF antibodies as described in section 2. 
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the basal growth, we studied the ffect of the anti- 
rbFGF antibodies. First, we checked the specificity 
of the antibodies by immunoblot analysis. As 
shown in fig.2, the antibodies reacted with rbFGF 
and showed no other cross-reacting bands in the E. 
coli lysate, indicating that the antibodies are 
specific to rbFGF. The antibodies were also con- 
firmed to react with bFGF derived from bovine 
pituitary by immunoblot analysis (not shown). 
Since these antibodies were raised to rbFGF pro- 
duced in E. coli, existence of antibodies against 
any other eucaryotic ell growth factors can be ex- 
cluded. 
The antibodies drastically inhibited the growth 
of BAE (CCL-207) cells in both the presence and 
absence of exogenous rbFGF, while normal IgG 
showed no effect (fig.l). 
To confirm that the BAE cells used in this study 
produced bFGF as reported for other endothelial 
cells [6,7], a BAE cell-free extract was examined 
for its proliferative activity on BCE cells. As 
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Fig.3. The effect of BAE cell-free extract on the proliferation 
of bovine capillary endothelial cells. BCE cells were plated at a 
density of 1 x 10 4 cells per 2 crn 2 well of gelatin-coated 
multiwell plate and cultured in the presence of the indicated 
concentrations of rbFGF (zx), or BAE ceil-free extract (o,e) 
with (e) or without (o) 13/zg/ml of anti-rbFGF antibodies. 
After 3 days, the cells were counted as described in fig.1. 
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Fig.4. Fractionation of BAE cell-free extract on a heparin 
affinity HPLC. BAE cell-free extract was fractionated as 
described in section 2. 10/A of each fraction was applied to 
BCE cell culture in 2 cm 2 well and assayed as described in fig.3. 
The elution position of bovine pituitary bFGF is indicated by an 
arrowhead. 
shown in fig.3, the extract induced the prolifera- 
tion of the ceils; 1/~1 of the extract was as effective 
as about 2 ng of rbFGF. Coincidently, a large 
amount of bFGF (1.6/~g/ml extract) was detected 
by radioimmuno assay in the cell-free extract (Dr 
M. Yamaoka, personal communication). This ac- 
tivity, as well as the basal growth of BCE cells, was 
completely neutralized by the anti-bFGF an- 
tibodies. The cell-free extract was fractionated on 
a heparin HPLC column (fig.4). The mitogenic ac- 
tivity for BCE cells was eluted at the same position 
as bovine pituitary bFGF. No activity was detected 
at 0.6 M NaCI on the column, where bovine 
pituitary acidic FGF is eluted. 
4. DISCUSSION 
The inhibitory effect of  the anti-rbFGF an- 
tibodies on the BAE cells clearly indicates that the 
bFGF acts via specific receptors expressed on the 
cell surface. The BAE cells produce a large amount 
of mitogenic activity and store it intracellularly. 
From the reactivity with the specific anti-rbFGF 
antibodies (fig. 3) and the chromatographic 
behavior on heparin HPLC (fig.4), it was confirm- 
ed that the activity was due to bFGF. Taken 
together, there is no doubt that BAE cells produce 
bFGF and that it induces the proliferation of BAE 
cells via an extracellular autocrine loop. 
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On the other hand, we were unable to detect 
bFGF activity in the conditioned medium of BAE 
cells by the mitogen assay (less than 0.04 ng/ml). 
Vlodavsky et al. [6] pointed out that bovine 
vascular aortic endothelial cells isolated from aor- 
tic arches ynthesize and deposit he bFGF into the 
subendothelial extracellular matrix. It is likely that 
the bFGF produced by BAE cells is also deposited 
into the matrix and exerts the proliferative ffect. 
Schweigerer et al. [7] reported that bovine 
capillary endothelial cells also produce bFGF and 
suggested that bFGF exerts the effect via receptors 
on the cell surface. However, their rabbit an- 
tibodies showed only very weak inhibition of the 
basal growth of capillary endothelial cells. 
Although the low efficiency may have resulted 
from masking of the epitopes of endogenous bFGF 
by the extracellular matrix [7], it did not provide 
direct evidence for the autocrine growth stimula- 
tion model. 
Consistent with our results, Sasada et al. [17] 
reported that the morphologic transformation i - 
duced by the expression of human bFGF cDNA in 
mouse BALB/c3T3 was reversed by adding our 
anti-rbFGF antibodies. It was also concluded that 
bFGF is produced and stored in the transformed 
mouse fibroblast cells and that it exerts its 
mitogenic effect via receptors on the cell surface. 
bFGF has no typical signal sequence [18,19] sug- 
gesting that it may be transported to the outside of 
the cell via a different pathway from that of nor- 
mal secretory proteins. The transport and secretion 
mechanisms are to be elucidated. 
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